Depression induced by chronic stress leads to penile cavernosal dysfunction: protective effect of anti-TNF-α treatment

Can J Physiol Pharmacol. 2018 Sep;96(9):933-942. doi: 10.1139/cjpp-2017-0778. Epub 2018 Jul 27.

Abstract

Psychological stress may lead to erectile dysfunction (ED), and inflammation has been evaluated as a major contributing factor. The goal of this study was to investigate the effects of etanercept (ETN), an anti-tumor necrosis factor α (TNF-α) protein, on cavernosal function in the unpredictable chronic mild stress (UCMS) rat model of depression. Animals were divided into 4 groups: animals not exposed to UCMS, animals not exposed to UCMS and treated with ETN, animals exposed to UCMS, and animals treated with ETN while exposed to UCMS. UCMS significantly impaired the neurogenic and endothelium-dependent relaxation responses; reduced cavernosal endothelial nitric oxide (NO) synthase (eNOS) and neuronal NO synthase (nNOS) expressions; decreased testosterone levels; enhanced systemic levels of corticosterone, TNF-α, interleukin 1β (IL-1β), interleukin 6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), and intercellular adhesion molecule 1 (ICAM-1); and also increased cavernosal levels of TNF-α, IL-1β, and IL-6 in rats. ETN administration restored NO-mediated neurogenic and endothelium-dependent relaxation responses of the corpus cavernosum, increased cavernosal eNOS and nNOS expressions, enhanced testosterone levels, and decreased corticosterone levels in UCMS-exposed rats. Also, systemic inflammatory markers and cavernosal proinflammatory cytokine levels were reduced by ETN. Our results demonstrate the role of TNF-α-mediated inflammation in the development of depression and ED in rats exposed to chronic stress.

Keywords: TNF-α; dysfonction érectile; erectile dysfunction; inflammation; stress léger imprévisible chronique; unpredictable chronic mild stress.

MeSH terms

  • Animals
  • Behavior, Animal
  • Body Weight
  • Depression / physiopathology
  • Depression / psychology*
  • Depression / therapy*
  • Endothelium / metabolism
  • Erectile Dysfunction / psychology*
  • Etanercept / immunology*
  • Etanercept / therapeutic use*
  • Gene Expression Regulation, Enzymologic
  • Locomotion
  • Male
  • Nitric Oxide Synthase Type I / genetics
  • Nitric Oxide Synthase Type III / genetics
  • Rats
  • Rats, Wistar
  • Stress, Psychological / psychology*
  • Time Factors
  • Tumor Necrosis Factor-alpha / immunology*
  • Vasodilation

Substances

  • Tumor Necrosis Factor-alpha
  • Nitric Oxide Synthase Type I
  • Nitric Oxide Synthase Type III
  • Etanercept